Table 1.
Crude prevalence of major health outcomes during the 2012–2017 period in 132,628 participants.
| At least one current long-term disease (ALD*) in all participants (n = 132,628) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Between 2012 and 2017 | In 2015 | In 2016 | In 2017 | |||||
| ALD categories | n | ‰ | n | ‰ | n | ‰ | n | ‰ |
| 1- Disabling stroke | 706 | 5.3 | 488 | 3.7 | 546 | 4.1 | 613 | 4.6 |
| 5- Severe heart failure, arrhythmias, valvular cardiomyopathy, congenital cardiomyopathy | 1,257 | 9.5 | 854 | 6.4 | 1,005 | 7.6 | 1,182 | 8.9 |
| 6- Active chronic diseases of the liver and cirrhosis | 487 | 3.7 | 368 | 2.8 | 367 | 2.8 | 382 | 2.9 |
| 7- Primary severe immunodeficiency requiring long-term treatment, infection by HIV virus | 356 | 2.7 | 332 | 2.5 | 346 | 2.6 | 348 | 2.6 |
| 8- Diabetes mellitus types 1 & 2 | 3,155 | 23.8 | 2,478 | 18.7 | 2,780 | 21.0 | 3,098 | 23.4 |
| 13- Coronary heart disease (CHD) | 2,244 | 16.9 | 1,700 | 12.8 | 1,939 | 14.6 | 2,180 | 16.4 |
| 16- Parkinson's disease | 182 | 1.4 | 131 | 1.0 | 150 | 1.1 | 179 | 1.3 |
| 19- Chronic nephropathy and primary nephrotic syndrome | 221 | 1.7 | 171 | 1.3 | 186 | 1.4 | 204 | 1.5 |
| 22- Severe evolutive rheumatoid polyarthritis | 507 | 3.8 | 391 | 2.9 | 434 | 3.3 | 466 | 3.5 |
| 23- Long-term psychiatric conditions | 2,659 | 20.0 | 2,095 | 15.8 | 2,266 | 17.1 | 2,336 | 17.6 |
| 24- Ulcerative colitis and evolutive Crohn's disease | 581 | 4.4 | 501 | 3.8 | 507 | 3.8 | 523 | 3.9 |
| 25- Multiple sclerosis (MS) | 264 | 2.0 | 231 | 1.7 | 245 | 1.8 | 259 | 2.0 |
| 27- Severe ankylosing spondylitis | 635 | 4.8 | 516 | 3.9 | 558 | 4.2 | 603 | 4.5 |
| 30- Malignant tumors, malignant lymphatic or haematopoietic tissue | 6,590 | 49.7 | 4,577 | 34.5 | 4,841 | 36.5 | 5,231 | 39.4 |
*
ALD (“Affection Longue Durée”): serious chronic disease.